-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Reata Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2022.
- Reata Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was $193M.
- Reata Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$87.6M, a 71.2% increase year-over-year.
- Reata Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$312M, a 4.88% decline from 2021.
- Reata Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$297M, a 20% decline from 2020.
- Reata Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$248M, a 14.6% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)